companydata.dkCAND.PHARM. POVL M. ASSENS FOND: Financial statements 2024
CVR: 14536604
CAND.PHARM. POVL M. ASSENS FOND (CVR 14536604) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 0 and a net result of DKK 11,790,112 compared with DKK 7,149,344 the year before. Equity amounted to DKK 117,469,209. The solvency ratio was 97.8%. The company had 52 employees in the financial year.
- Revenue
- 0 kr.
- Profit/Loss
- 11,790,112 kr.
- Equity
- 117,469,209 kr.
- Total Assets
- 120,106,675 kr.
- Employees
- 52
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 0 | - | 11.8 mio. | 117.5 mio. | 52 |
| 2023 | 0 | 0 | 7.1 mio. | 107.1 mio. | 53 |
| 2022 | - | - | -3.3 mio. | 101.7 mio. | 47 |
| 2021 | 0 | 0 | 7.3 mio. | 106.1 mio. | 41 |
| 2020 | 0 | 0 | 145 t. | 101.2 mio. | 37 |
How creditworthy is CAND.PHARM. POVL M. ASSENS FOND?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2023. Revenue came to DKK 0, and the net result was DKK 7,149,344.
About CAND.PHARM. POVL M. ASSENS FOND
CAND.PHARM. POVL M. ASSENS FOND is a Danish company of the type Erhvervsdrivende fond based in Glostrup, founded in 1999. The company is registered under the industry Støtteaktiviteter relateret til sygdomsbekæmpende, sociale og velgørende formål. The company has 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 13,153,000 compared with DKK 11,790,112 the year before. Equity amounted to DKK 128,614,000.